Fundraising Fox

CaroGen Corporation

Farmington, US · Founded 2012 · 10 employees on LinkedIn · 1 known investors

CaroGen Corporation develops immunotherapies for cancer and infectious diseases based on an enveloped self-amplifying mRNA (virus-like vesicle) platform, with lead candidates including CARG-2020 for ovarian and other cancers and CARG-201 for hepatitis B. The company works with academic and government partners such as Wayne State University, UConn Health, and NIH/NIAID.

BiotechHealthtech

Founders & leadership

CaroGen Corporation was founded in 2012 by Bijan Almassian.

BA
Bijan AlmassianinCEO
VN
Valerian NakaarChief Scientific Officer & Board Member
DC
Deborah ChurchChief Medical Officer
KL
King LeeVP, Regulatory Affairs
TY
Timur YarovinksyVP, Discovery
JR
Joseph RiningerVP, Product Development

Investors · 1

Connecticut InnovationsNew Haven · $500K – $2M

Competitors · 5

by search overlap
Biogen Idec19 shared keywordsBiogen is a biotechnology company founded in 1978 that focuses on breakthroughs in biology. The company serves patients through research and development in the life sciences industry.
Compugen14 shared keywordsCompugen develops immuno-oncology therapeutics using Unigen, a computational platform that combines scientific research with AI/ML to identify novel drug targets and design first-in-class antibody drugs. Its therapeutic antibodies targeting novel pathways are being evaluated in multiple clinical trials.
Wugen14 shared keywordsAllotera (formerly Wugen) develops allogeneic T-cell therapies. The company focuses on cell and gene therapy approaches for treating disease.
Cullgen12 shared keywordsCullgen is a privately held biopharmaceutical company developing first-in-class drugs based on its uSMITE™ (small-molecule induced ubiquitin-dependent target elimination) targeted protein degradation platform, which uses the ubiquitin-proteasome system and E3 ubiquitin ligases to target disease-causing proteins that conventional small-molecule drugs cannot reach. The company focuses on oncology and immune-related diseases and operates R&D and offices in both China and the United States.
Precigen11 shared keywordsPrecigen is a biopharmaceutical company developing gene and cell therapies, including PAPZIMEOS (zopapogene imadenovec-drba), an FDA-approved immunotherapy for adults with recurrent respiratory papillomatosis. The company focuses on immuno-oncology and immunotherapy treatments delivered via subcutaneous injection.

Companies competing with CaroGen Corporation for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 4 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2021$3M
National Institutes of Health (NIH)National Institutes of HealthPhase I2020$300K
National Institutes of Health (NIH)National Institutes of HealthPhase II2019$1.4M
National Institutes of Health (NIH)National Institutes of HealthPhase I2018$224.7K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

CaroGen’s Hepatitis B vaccine recommended for $6.8M in federal fundinghartfordbusiness.com · Jan 2022CaroGen Corporation Raises $150K in Funding - FinSMEsfinsmes.com · Sep 2013

Frequently asked questions

What does CaroGen Corporation do?
CaroGen Corporation develops immunotherapies for cancer and infectious diseases based on an enveloped self-amplifying mRNA (virus-like vesicle) platform, with lead candidates including CARG-2020 for ovarian and other cancers and CARG-201 for hepatitis B. The company works with academic and government partners such as Wayne State University, UConn Health, and NIH/NIAID.
Who founded CaroGen Corporation?
CaroGen Corporation was founded by Bijan Almassian in 2012.
Who are CaroGen Corporation's investors?
CaroGen Corporation's investors include Connecticut Innovations.
Where is CaroGen Corporation headquartered?
CaroGen Corporation is headquartered in Farmington, US.